News

Alopecia areata, an autoimmune disorder causing hair loss, now has an FDA-approved treatment since June 2022. While some ...
Alopecia areata, an autoimmune condition, leads to patchy hair loss due to immune system attacks on hair follicles. Garlic, with its allicin and sulfu ...
Sun Pharmaceutical Industries, announced its release of Leqselvi in the U.S. earlier this week. Leqselvi™ is currently ...
A new study offers insights into the relative efficacy of various treatments for alopecia areata (AA), suggesting that deuruxolitinib (Leqselvi; Sun Pharma) at a dosage of 12 mg twice daily for 24 ...
AA is linked to increased anxiety and depression, especially in females and younger patients, with variations across countries. The study found significant associations between AA and mental health in ...
In this personal essay, hairstylist and curl expert Kys Clark shares how having alopecia has redefined what beauty means to ...
Baldness is a condition that affects a great many different people, and it's not always caused by the same things. Fittingly, ...
Do you often find yourself experiencing more bad hair days than good ones in winter? Allow our experts to assist you in ...
Sun Pharma has introduced LEQSELVITM (deuruxolitinib) 8 mg tablets in the US for severe alopecia areata after settling a ...
With thousands of press releases published each week, it can be difficult to keep up with everything on PR Newswire. To help ...
Mumbai: Sun Pharmaceutical Industries Limited has announced the incorporation of a subsidiary company, Sun Pharma (Hainan) ...
Leqselvi ™ (deuruxolitinib) is now available for the treatment of adults with severe alopecia areata.